Clinical trial

Treatment Satisfaction With Ra-223 in Japan

NCT03315260

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-04-11

PhaseN/A

Study timeline

Study start (actual)2019-04-11Date precision: day

Registry last updated2024-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

Radium-223 dichloride (Xofigo, BAY88-8223)DRUG

Sponsors & collaborators

Bayerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03315260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.